Literature DB >> 22203234

Is thyroid-stimulating hormone within the normal reference range a risk factor for atherosclerosis in women?

Anna Boggio1, Fulvio Muzio, Michela Fiscella, Domenico Sommariva, Adriana Branchi.   

Abstract

The relationship between overt hypothyroidism and cardiovascular risk has been well documented and some data also suggest an association between cardiovascular risk and subclinical hypothyroidism. The aim of our study was to investigate, in a large cohort of euthyroid women, the association of thyroid stimulating hormone (TSH) within the normal reference range with cardiovascular risk factors. The study was carried out on 744 women with normal thyroid function (TSH 0.3-4.9 μU/mL). Women with TSH above the median (≥2.1 μU/mL) were more obese, had greater waist girth, were more hypertensive and had higher levels of total cholesterol (TC), serum triglycerides (TG), blood sugar (BG) and lower levels of HDL-cholesterol (HDL-C) than women with TSH below the median. TSH was significantly correlated with body mass index (BMI), waist circumference, BG, TG, TC, HDL-C and hypertension. Multiple backward stepwise regression analysis with age, waist circumference and TSH as independent variables confirmed the strong association of TSH with BG, TG, HDL-C and hypertension. A total of 205 patients (28%) fulfilled the definition criteria of the metabolic syndrome and the prevalence of metabolic syndrome was significantly greater in patients with TSH above than in patients with TSH below the median. Results of logistic analysis, including age and TSH as predictor variables, confirmed the association of TSH with metabolic syndrome.The results of this study suggest that TSH in the upper limits of the reference range (above 2.1 μU/ml) is associated with a less favourable cardiometabolic profile and consequently with a higher risk of developing cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22203234     DOI: 10.1007/s11739-011-0743-z

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  42 in total

Review 1.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein; K Ojamaa
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

Review 2.  Review: molecular thyroidology.

Authors:  W E Winter; M R Signorino
Journal:  Ann Clin Lab Sci       Date:  2001-07       Impact factor: 1.256

3.  Relationship of thyroid function with body mass index and insulin-resistance in euthyroid obese subjects.

Authors:  B Ambrosi; B Masserini; L Iorio; A Delnevo; A E Malavazos; L Morricone; L F Sburlati; E Orsi
Journal:  J Endocrinol Invest       Date:  2010-03-25       Impact factor: 4.256

4.  Subclinical thyroid dysfunction as a risk factor for cardiovascular disease.

Authors:  John P Walsh; Alexandra P Bremner; Max K Bulsara; Peter O'Leary; Peter J Leedman; Peter Feddema; Valdo Michelangeli
Journal:  Arch Intern Med       Date:  2005-11-28

5.  Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux-en-Y gastric bypass.

Authors:  Cristiane M Moulin de Moraes; Marcio C Mancini; Maria Edna de Melo; Daniela Andraus Figueiredo; Sandra Mara F Villares; Alessandra Rascovski; Bruno Zilberstein; Alfredo Halpern
Journal:  Obes Surg       Date:  2005-10       Impact factor: 4.129

6.  Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat.

Authors:  Ian Janssen; Steven B Heymsfield; David B Allison; Donald P Kotler; Robert Ross
Journal:  Am J Clin Nutr       Date:  2002-04       Impact factor: 7.045

7.  Changes in lifestyle improve body composition, thyroid function, and structure in obese children.

Authors:  G Radetti; S Longhi; M Baiocchi; W Cassar; F Buzi
Journal:  J Endocrinol Invest       Date:  2011-05-27       Impact factor: 4.256

8.  TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects.

Authors:  Jose de Jesus Garduño-Garcia; Ulices Alvirde-Garcia; Guadalupe López-Carrasco; Ma Elena Padilla Mendoza; Roopa Mehta; Olimpia Arellano-Campos; Ricardo Choza; Leobardo Sauque; Maria Eugenia Garay-Sevilla; Juan Manuel Malacara; Francisco J Gomez-Perez; Carlos A Aguilar-Salinas
Journal:  Eur J Endocrinol       Date:  2010-06-01       Impact factor: 6.664

9.  Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects.

Authors:  Annemieke Roos; Stephan J L Bakker; Thera P Links; Rijk O B Gans; Bruce H R Wolffenbuttel
Journal:  J Clin Endocrinol Metab       Date:  2006-11-07       Impact factor: 5.958

10.  Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism?

Authors:  Mario Rotondi; Paola Leporati; Antonella La Manna; Barbara Pirali; Teresa Mondello; Rodolfo Fonte; Flavia Magri; Luca Chiovato
Journal:  Eur J Endocrinol       Date:  2008-12-10       Impact factor: 6.664

View more
  7 in total

1.  Evaluation of biochemical, hematological, and thyroid function parameters in nondipper and dipper hypertensive patients.

Authors:  Ibrahim Akpinar; Nurcan Basar; Nihat Sen; Halil Lutfu Kisacik
Journal:  Wien Klin Wochenschr       Date:  2012-07-06       Impact factor: 1.704

2.  Biochemically diagnosed hypothyroidism and postoperative complications after cardiac surgery: a retrospective cohort analysis.

Authors:  Ryu Komatsu; Nika Karimi; Nicole M Zimmerman; Daniel I Sessler; C A Bashour; Edward G Soltesz; Alparslan Turan
Journal:  J Anesth       Date:  2018-07-16       Impact factor: 2.078

3.  A high normal TSH level is associated with an atherogenic lipid profile in euthyroid non-smokers with newly diagnosed asymptomatic coronary heart disease.

Authors:  Xing Wanjia; Wang Chenggang; Wang Aihong; Yang Xiaomei; Zhao Jiajun; Yu Chunxiao; Xu Jin; Hou Yinglong; Gao Ling
Journal:  Lipids Health Dis       Date:  2012-03-27       Impact factor: 3.876

4.  The Lipid Parameters and Lipoprotein(a) Excess in Hashimoto Thyroiditis.

Authors:  D O Yetkin; B Dogantekin
Journal:  Int J Endocrinol       Date:  2015-05-03       Impact factor: 3.257

5.  Lower normal free thyroxine is associated with a higher risk of metabolic syndrome: a retrospective cohort on Chinese population.

Authors:  Xi Ding; Chun-Ying Zhu; Rui Li; Li-Ping Wu; Yue Wang; Shi-Qian Hu; Yi-Ming Liu; Feng-Yi Zhao; Yang Zhao; Meng Zhang; Ming-Qian He; Zi-Yi Chen; Bing-Yin Shi
Journal:  BMC Endocr Disord       Date:  2021-03-04       Impact factor: 2.763

6.  High-normal thyroid-stimulating hormone in euthyroid subjects is associated with risk of mortality and composite disease endpoint only in women.

Authors:  Servet Altay; Altan Onat; Günay Can; Eyyup Tusun; Barış Şimşek; Adnan Kaya
Journal:  Arch Med Sci       Date:  2016-10-26       Impact factor: 3.318

7.  Prognostic Value of Normal Thyroid Stimulating Hormone in Long-Term Mortality in Patients With STEMI.

Authors:  Lijie Sun; Keling Xiao; Zupei Miao; Yinghua Zhang; Jin Si; Ning Shi; Haoyu Zhang; Ting Zhao; Jing Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-22       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.